Associations of birth outcomes with maternal polybrominated diphenyl ethers and thyroid hormones during pregnancy

Marie Lynn Miranda1, Rebecca Anthopolos2, Amy Wolkin3

  • 1School of Natural Resources and Environment, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109, USA.

Insights

Maternal exposure to polybrominated diphenyl ethers (PBDEs) may be linked to smaller infant head circumference. Thyroid hormones did not appear to mediate this association in this study of PBDEs and birth outcomes.

Area of Science:

  • Environmental Health
  • Reproductive Toxicology
  • Pediatric Health

Background:

  • Polybrominated diphenyl ethers (PBDEs) are flame retardants with known associations with adverse birth outcomes and thyroid disruption.
  • Understanding the impact of prenatal exposure to PBDEs on infant development is crucial for public health.

Purpose of the Study:

  • To investigate the association between maternal serum PBDE levels and infant anthropometric measurements including birth weight, head circumference, and length.
  • To explore the potential mediating role of maternal thyroid hormone levels in these associations.

Main Methods:

  • A cohort of 140 pregnant women was recruited during their third trimester.
  • Maternal serum was analyzed for PBDEs and thyroid hormones; infant birth outcomes were collected from medical records.

Main Results:

  • Maternal BDE 153 showed a potential association with reduced infant head circumference, though this was attenuated after adjusting for covariates.
  • Other PBDE congeners (BDE 47, 99) showed non-significant negative associations with infant measurements.
  • Thyroid hormone levels did not appear to mediate the relationship between PBDEs and infant outcomes.

Conclusions:

  • Maternal PBDE exposure may be associated with decreased infant head circumference, warranting further investigation in larger populations.
  • The data did not support a mediating role for thyroid hormones in the observed associations.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
9.0K
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
71.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
6.7K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
4.0K